Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

被引：0

作者：

Shohei Eto

Yoko Nukui

Miyuki Tsumura

Yu Nakagama

Kenichi Kashimada

Yoko Mizoguchi

Takanori Utsumi

Maki Taniguchi

Fumiaki Sakura

Kosuke Noma

Yusuke Yoshida

Shinichiro Ohshimo

Shintaro Nagashima

Keisuke Okamoto

Akifumi Endo

Kohsuke Imai

Hirokazu Kanegane

Hidenori Ohnishi

Shintaro Hirata

Eiji Sugiyama

Nobuaki Shime

Masanori Ito

Hiroki Ohge

Yasutoshi Kido

Paul Bastard

Jean-Laurent Casanova

Osamu Ohara

Junko Tanaka

Tomohiro Morio

Satoshi Okada

机构：

[1] Hiroshima University Graduate School of Biomedical and Health Science,Department of Pediatrics

[2] Tokyo Medical and Dental University Hospital,Department of Infection Control and Prevention

[3] Kyoto Prefectural University of Medicine,Department of Infection Control and Laboratory Medicine

[4] Osaka City University,Department of Parasitology, Graduate School of Medicine

[5] Tokyo Medical and Dental University,Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences

[6] Hiroshima University Hospital,Department of Clinical Immunology and Rheumatology

[7] Hiroshima University Graduate School of Biomedical and Health Science,Department of Emergency and Critical Care Medicine

[8] Hiroshima University Graduate School of Biomedical and Health Sciences,Department of Epidemiology Infectious Disease Control and Prevention

[9] Tokyo Medical and Dental University Hospital,Clinical Research Center

[10] Tokyo Medical and Dental University,Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences

[11] Tokyo Medical and Dental University,Department of Child Health and Development

[12] Gifu University Graduate School of Medicine,Department of Pediatrics

[13] Emeritus Professor of Hiroshima University,Department of General Internal Medicine

[14] Hiroshima University Hospital,Department of Infectious Diseases

[15] Hiroshima University Hospital,Laboratory of Human Genetics of Infectious Diseases, Necker Branch

[16] INSERM U1163,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch

[17] Necker Hospital for Sick Children,Department of Applied Genomics

[18] University of Paris,undefined

[19] Imagine Institute,undefined

[20] The Rockefeller University,undefined

[21] Howard Hughes Medical Institute,undefined

[22] Kazusa DNA Research Institute,undefined

来源：

Journal of Clinical Immunology | 2022年 / 42卷

关键词：

COVID-19; Antibodies to type I IFNs; IFN-α2; IFN-ω; Neutralization assay; IFN-α2 concentration;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1360 / 1370

页数：10

共 50 条

[31] The role of type I interferon in the treatment of COVID-19
Sodeifian, Fatemeh
Nikfarjam, Mahsa
Kian, Naghmeh
Mohamed, Kawthar
Rezaei, Nima
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (01) : 63 - 81
[32] Dysregulation of type I interferon responses in COVID-19
Acharya, Dhiraj
Liu, GuanQun
Gack, Michaela U.
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (07) : 397 - 398
[33] Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia
Philippot, Quentin C.
Fekkar, Arnaud
Gervais, Adrian
Le Voyer, Tom
Boers, Leonoor
Conil, Clement
Bizien, Lucy
de Brabander, Justin
Duitman, Jan Willem
Romano, Alessia
Rosain, Jeremie
Blaize, Marion
Migaud, Melanie
Jeljeli, Maxime
Hammadi, Boualem
Desmons, Aurore
Marchal, Astrid
ArtDECO Consortium
COVID HGE Consortium
Mayaux, Julien
Zhang, Qian
Jouanguy, Emmanuelle
Borie, Raphael
Crestani, Bruno
Luyt, Charles Edouard
Adle-Biassette, Homa
Sene, Damien
Megarbane, Bruno
Cobat, Aurelie
Bastard, Paul
Bos, Lieuwe D. J.
Casanova, Jean-Laurent
Puel, Anne
JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1093 - 1103
[34] Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia
Quentin Philippot
Arnaud Fekkar
Adrian Gervais
Tom Le Voyer
Leonoor S. Boers
Clément Conil
Lucy Bizien
Justin de Brabander
Jan Willem Duitman
Alessia Romano
Jérémie Rosain
Marion Blaize
Mélanie Migaud
Maxime Jeljeli
Boualem Hammadi
Aurore Desmons
Astrid Marchal
Julien Mayaux
Qian Zhang
Emmanuelle Jouanguy
Raphael Borie
Bruno Crestani
Charles Edouard Luyt
Homa Adle-Biassette
Damien Sene
Bruno Megarbane
Aurélie Cobat
Paul Bastard
Lieuwe D. J. Bos
Jean-Laurent Casanova
Anne Puel
Journal of Clinical Immunology, 2023, 43 : 1093 - 1103
[35] Type I interferon, anti-interferon antibodies, and COVID-19
Calabrese, Leonard H.
Winthrop, Kevin
Strand, Vibeke
Yazdany, Jinoos
Walter, Jolan E.
LANCET RHEUMATOLOGY, 2021, 3 (04): : E246 - E247
[36] Critical COVID-19 disease explained by type I interferon autoantibodies found in patients within the Military Health System.
Leondaridis, Maria A.
Yee, Debra
Tso, Marana
Shaw, Elana
Rosen, Lindsey B.
Samuels, Emily
Bastard, Paul
Casanova, Jean-Laurent
Holland, Steven M.
Su, Helen C.
Richard, Stephanie
Mende, Katrin
Lalani, Tahaniyat
Lindholm, David
Berjohn, Catherine M.
Maves, Ryan
Colombo, Rhonda
Colombo, Christopher
Larson, Derek
Ewers, Evan
Ganesan, Anuradha
Huprikar, Nikhil
Mody, Rupal M.
Jones, Milissa U.
Simons, Mark P.
Tribble, David
Laing, Eric
Agan, Brian
Pollett, Simon
Burgess, Timothy
Snow, Andrew L.
JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
[37] Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, Paul
Rosen, Lindsey B.
Zhang, Qian
Michailidis, Eleftherios
Hoffmann, Hans-Heinrich
Zhang, Yu
Dorgham, Karim
Philippot, Quentin
Rosain, Jeremie
Beziat, Vivien
Manry, Jeremy
Shaw, Elana
Haljasmagi, Liis
Peterson, Part
Lorenzo, Lazaro
Bizien, Lucy
Trouillet-Assant, Sophie
Dobbs, Kerry
de Jesus, Adriana Almeida
Belot, Alexandre
Kallaste, Anne
Catherinot, Emilie
Tandjaoui-Lambiotte, Yacine
Le Pen, Jeremie
Kerner, Gaspard
Bigio, Benedetta
Seeleuthner, Yoann
Yang, Rui
Bolze, Alexandre
Spaan, Andras N.
Delmonte, Ottavia M.
Abers, Michael S.
Aiuti, Alessandro
Casari, Giorgio
Lampasona, Vito
Piemonti, Lorenzo
Ciceri, Fabio
Bilguvar, Kaya
Lifton, Richard P.
Vasse, Marc
Smadja, David M.
Migaud, Melanie
Hadjadj, Jerome
Terrier, Benjamin
Duffy, Darragh
Quintana-Murci, Lluis
van de Beek, Diederik
Roussel, Lucie
Vinh, Donald C.
Tangye, Stuart G.
SCIENCE, 2020, 370 (6515) : 423 - +
[38] Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis
Lemarquis, Andri
Campbell, Tessa
Aranda-Guillen, Maribel
Hennings, Viktoria
Brodin, Petter
Kampe, Olle
Blennow, Kaj
Zetterberg, Henrik
Wenneras, Christine
Eriksson, Kristina
Landegren, Nils
Bryceson, Yenan
Berg, Stefan
Ekwall, Olov
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (01) : 96 - 98
[39] Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients
Zhenling Wang
Hailong Pan
Boguang Jiang
Signal Transduction and Targeted Therapy, 5
[40] Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients
Wang, Zhenling
Pan, Hailong
Jiang, Boguang
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)

← 1 2 3 4 5 →